logo
ProjectActive

BioVac - Pfizer

The status, timeline and source of this project. A free account opens every field.

Source: IFC Project Disclosures

The project entails a financing package of $25 million to BioVac Limited (“BioVac” or the “Company”) a South African based biopharma company to support their vaccine manufacturing capabilities. The Company is planning to expand their operations through a 2-part project the first of which involves manufacturing the Pfizer COVID-19 vaccine (fill and finish only) and IFC will finance this via a $7 m

Status
Prospective
Sector
Manufacturing (Industrial), Raw Materials, Fertilizers, Commercial
Location
South Africa
Updated
19 Nov 2026
Source
IFC Project Disclosures

ConstructChat

Ask ConstructChat about BioVac - Pfizer

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “BioVac - Pfizer” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in South Africa. Taiyo aggregates data on it from IFC Project Disclosures.

Participants

Not available for this record.

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

The project entails a financing package of $25 million to BioVac Limited (“BioVac” or the “Company”) a South African based biopharma company to support their vaccine manufacturing capabilities. The Company is planning to expand their operations through a 2-part project the first of which involves manufacturing the Pfizer COVID-19 vaccine (fill and finish only) and IFC will finance this via a $7 million loan. The second component includes construction of new multi-vaccine facility. IFC will provide $500k funding to support the bankable feasibility study for this facility (~130 million doses annually) and provide $7.5 million in equity (~12.5% stake) and a $10 million loan to support the actual development. The main facility at BioVac consists of 6 buildings spanning some 5,500 m2 in total surface area. A new building has been constructed (building E) to house the “freezer farm” as required for the storage of vaccines. In addition, a 50-tonne capacity liquid nitrogen tank has been installed.          

Original sector

other

Location

Country

South Africa

Source

Source

IFC Project Disclosures

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Raw Materials, Fertilizers, Commercial

Article published date

2026-09-09

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project